Regenxbio Inc(RGNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RGNX Regenxbio Inc

未开盘 01-02 16:00:00 EST

13.57

-0.83

-5.76%

盘后13.57

+0.000.00%

19:11 EST

最高14.65	最低12.91	成交量132.70万
今开14.65	昨收14.40	日振幅12.08%
总市值6.87亿	流通市值5.62亿	总股本5,062万
成交额1,773万	换手率3.20%	流通股本4,142万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RGNX","market":"US","secType":"STK","nameCN":"Regenxbio Inc","latestPrice":13.57,"timestamp":1767387600000,"preClose":14.4,"halted":0,"volume":1326971,"hourTrading":{"tag":"盘后","latestPrice":13.57,"preClose":13.57,"latestTime":"19:11 EST","volume":19619,"amount":266207.63,"timestamp":1767399105210},"delay":0,"floatShares":41423137,"shares":50623086,"eps":-3.46438,"marketStatus":"未开盘","change":-0.83,"latestTime":"01-02 16:00:00 EST","open":14.65,"high":14.65,"low":12.91,"amount":17729019.930978,"amplitude":0.120833,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.46438,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1767603600000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1442462400000,"exchange":"NASDAQ","adjPreClose":14.4,"preHourTrading":{"tag":"盘前","latestPrice":14.77,"preClose":14.4,"latestTime":"09:28 EST","volume":1005,"amount":14923.533435000001,"timestamp":1767364080011},"postHourTrading":{"tag":"盘后","latestPrice":13.57,"preClose":13.57,"latestTime":"19:11 EST","volume":19619,"amount":266207.63,"timestamp":1767399105210},"volumeRatio":1.905570838887039,"impliedVol":0.858,"impliedVolPercentile":0.608},"requestUrl":"/m/hq/s/RGNX","defaultTab":"news","newsList":[{"id":"2600013838","title":"Regenxbio Inc.盘中异动 早盘股价大跌5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600013838","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600013838?lang=zh_cn&edition=full","pubTime":"2026-01-02 22:35","pubTimestamp":1767364508,"startTime":"0","endTime":"0","summary":"北京时间2026年01月02日22时35分，Regenxbio Inc.股票出现异动，股价急速跳水5.97%。截至发稿，该股报13.54美元/股，成交量4.7624万股，换手率0.09%，振幅5.38%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Regenxbio Inc.公司简介：Regenxbio Inc 是一家生物技术公司。Regenxbio 平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102223508a494ed46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102223508a494ed46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","BK4563","RGNX"],"gpt_icon":0},{"id":"2585719853","title":"Regenxbio Inc.盘中异动 早盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585719853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585719853?lang=zh_cn&edition=full","pubTime":"2025-11-20 22:30","pubTimestamp":1763649039,"startTime":"0","endTime":"0","summary":"北京时间2025年11月20日22时30分，Regenxbio Inc.股票出现波动，股价大幅上涨5.03%。截至发稿，该股报11.48美元/股，成交量5916股，换手率0.01%，振幅0.00%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Regenxbio Inc.公司简介：Regenxbio Inc 是一家生物技术公司。Regenxbio 平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120223040a4af7909&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120223040a4af7909&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","RGNX","BK4139","BK4563"],"gpt_icon":0},{"id":"1188076388","title":"Regenxbio第三季度许可证和版税收入2360.5万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1188076388","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188076388?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:58","pubTimestamp":1763571520,"startTime":"0","endTime":"0","summary":"11月6日 - Regenxbio第三季度运营费用为8214.4万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RGNX","BK4505","BK4563"],"gpt_icon":0},{"id":"2583655048","title":"Regenxbio Inc.2025财年第三财季实现净利润-61.94百万美元，同比减少3.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583655048","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583655048?lang=zh_cn&edition=full","pubTime":"2025-11-16 00:00","pubTimestamp":1763222444,"startTime":"0","endTime":"0","summary":"11月16日，Regenxbio Inc.公布财报，公告显示公司2025财年第三财季净利润为-61.94百万美元，同比减少3.93%；其中营业收入为29.73百万美元，同比增加22.85%，每股基本收益为-1.20美元。从资产负债表来看，Regenxbio Inc.总负债3.64亿美元，其中短期债务50.79百万美元，资产负债比为1.45，流动比率为2.66。机构评级：截至2025年11月16日，当前有12家机构对Regenxbio Inc.目标价做出预测，其中目标均价为31.25美元，其中最低目标价为14.00美元，最高目标价为52.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251116000105976b721e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251116000105976b721e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX"],"gpt_icon":0},{"id":"1165405517","title":"Regenxbio宣布杜氏肌营养不良症基因治疗项目的关键登记完成并启动商业生产","url":"https://stock-news.laohu8.com/highlight/detail?id=1165405517","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165405517?lang=zh_cn&edition=full","pubTime":"2025-10-30 19:07","pubTimestamp":1761822443,"startTime":"0","endTime":"0","summary":"Regenxbio宣布杜氏肌营养不良症基因治疗项目的关键登记完成并启动商业生产","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4505","RGNX","BK4139"],"gpt_icon":0},{"id":"2578525592","title":"Regenxbio Inc.盘中异动 下午盘急速拉升5.17%报13.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578525592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578525592?lang=zh_cn&edition=full","pubTime":"2025-10-25 03:08","pubTimestamp":1761332894,"startTime":"0","endTime":"0","summary":"北京时间2025年10月25日03时08分，Regenxbio Inc.股票出现波动，股价快速上涨5.17%。截至发稿，该股报13.23美元/股，成交量25.4579万股，换手率0.50%，振幅3.66%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Regenxbio Inc.公司简介：Regenxbio Inc 是一家生物技术公司。Regenxbio 平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510250308149740e7ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510250308149740e7ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","RGNX","BK4563","BK4139"],"gpt_icon":0},{"id":"1104086468","title":"Regenxbio宣布完成湿性AMD视网膜下Surabgene Lomparvovec关键性试验的患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1104086468","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104086468?lang=zh_cn&edition=full","pubTime":"2025-10-06 19:06","pubTimestamp":1759748776,"startTime":"0","endTime":"0","summary":"Regenxbio宣布完成湿性AMD视网膜下Surabgene Lomparvovec关键性试验的患者入组","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4563","RGNX","BK4139"],"gpt_icon":0},{"id":"2570064837","title":"Regenxbio Inc.盘中异动 股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570064837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570064837?lang=zh_cn&edition=full","pubTime":"2025-09-25 00:19","pubTimestamp":1758730755,"startTime":"0","endTime":"0","summary":"北京时间2025年09月25日00时19分，Regenxbio Inc.股票出现波动，股价大幅拉升5.15%。截至发稿，该股报9.39美元/股，成交量11.5695万股，换手率0.23%，振幅4.44%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Regenxbio Inc.公司简介：Regenxbio Inc 是一家生物技术公司。Regenxbio 平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509250019159542d0c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509250019159542d0c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","BK4563","RGNX"],"gpt_icon":0},{"id":"1103266182","title":"Regenxbio公布RGX-121治疗MPS II的CAMPSIITE® I/II/III期关键试验12个月积极数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1103266182","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103266182?lang=zh_cn&edition=full","pubTime":"2025-09-05 19:05","pubTimestamp":1757070321,"startTime":"0","endTime":"0","summary":"Regenxbio公司发布了其治疗黏多糖贮积症II型(MPS II)药物RGX-121的CAMPSIITE® I/II/III期临床试验12个月关键数据，结果显示积极疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGNX","BK4139","BK4563","BK4505"],"gpt_icon":0},{"id":"2559936894","title":"Regenxbio Inc.盘中异动 股价大涨5.06%报8.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559936894","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559936894?lang=zh_cn&edition=full","pubTime":"2025-08-13 21:42","pubTimestamp":1755092579,"startTime":"0","endTime":"0","summary":"北京时间2025年08月13日21时42分，Regenxbio Inc.股票出现波动，股价急速上涨5.06%。截至发稿，该股报8.51美元/股，成交量3.6595万股，换手率0.07%，振幅3.40%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Regenxbio Inc.公司简介：Regenxbio Inc 是一家生物技术公司。Regenxbio 平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813214259a4867c52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813214259a4867c52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","RGNX","BK4563"],"gpt_icon":0},{"id":"2558066470","title":"Regenxbio Inc.盘中异动 急速跳水5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558066470","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558066470?lang=zh_cn&edition=full","pubTime":"2025-08-12 01:07","pubTimestamp":1754932058,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日01时07分，Regenxbio Inc.股票出现波动，股价快速下跌5.07%。截至发稿，该股报7.45美元/股，成交量30.858万股，换手率0.61%，振幅4.20%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Equillium, Inc.、Entero Therapeutics Inc.、Bioxcel Therapeutics, Inc.涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为5986.55%、599.70%、242.43%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.，振幅分别为84.05%、74.27%、62.69%。Regenxbio Inc.公司简介：Regenxbio Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812010739a6dffdd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812010739a6dffdd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","RGNX","BK4563"],"gpt_icon":0},{"id":"2557564851","title":"Regenxbio Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557564851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557564851?lang=zh_cn&edition=full","pubTime":"2025-08-07 22:14","pubTimestamp":1754576056,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日22时14分，Regenxbio Inc.股票出现波动，股价大幅下挫5.05%。截至发稿，该股报7.81美元/股，成交量19.2561万股，换手率0.38%，振幅5.71%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Regenxbio Inc.公司简介：Regenxbio Inc 是一家生物技术公司。Regenxbio 平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807221416a47b3677&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807221416a47b3677&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","BK4505","RGNX"],"gpt_icon":0},{"id":"2556190928","title":"Regenxbio Inc.盘中异动 股价大跌5.29%报8.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556190928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556190928?lang=zh_cn&edition=full","pubTime":"2025-08-01 21:31","pubTimestamp":1754055101,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日21时31分，Regenxbio Inc.股票出现异动，股价大幅下跌5.29%。截至发稿，该股报8.06美元/股，成交量1.5218万股，换手率0.03%，振幅2.00%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Regenxbio Inc.公司简介：Regenxbio Inc 是一家生物技术公司。Regenxbio 平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801213141a6cdeb02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801213141a6cdeb02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX","BK4139","BK4563","BK4505"],"gpt_icon":0},{"id":"2555706652","title":"Regenxbio Inc.盘中异动 下午盘大幅跳水5.12%报8.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555706652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555706652?lang=zh_cn&edition=full","pubTime":"2025-07-30 03:23","pubTimestamp":1753817033,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日03时23分，Regenxbio Inc.股票出现波动，股价大幅下跌5.12%。截至发稿，该股报8.34美元/股，成交量69.1799万股，换手率1.37%，振幅6.26%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Regenxbio Inc.公司简介：Regenxbio Inc 是一家生物技术公司。Regenxbio 平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073003235394c228ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073003235394c228ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","RGNX","BK4563"],"gpt_icon":0},{"id":"2552343831","title":"Regenxbio Inc.盘中异动 临近午盘快速拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552343831","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552343831?lang=zh_cn&edition=full","pubTime":"2025-07-17 23:34","pubTimestamp":1752766472,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日23时34分，Regenxbio Inc.股票出现异动，股价快速上涨5.24%。截至发稿，该股报8.95美元/股，成交量12.8725万股，换手率0.26%，振幅4.53%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Regenxbio Inc.公司简介：Regenxbio Inc 是一家生物技术公司。Regenxbio 平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717233432a6b02989&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717233432a6b02989&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","BK4563","RGNX"],"gpt_icon":0},{"id":"2551199660","title":"Regenxbio Inc.盘中异动 大幅跳水5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551199660","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551199660?lang=zh_cn&edition=full","pubTime":"2025-07-16 00:50","pubTimestamp":1752598251,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日00时50分，Regenxbio Inc.股票出现异动，股价快速下挫5.06%。截至发稿，该股报8.26美元/股，成交量16.341万股，换手率0.32%，振幅6.61%。Regenxbio Inc.股票所在的生物技术行业中，整体跌幅为1.11%。Regenxbio Inc.公司简介：Regenxbio Inc 是一家生物技术公司。Regenxbio 平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716005051a44cd341&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716005051a44cd341&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX","BK4505","BK4139","BK4563"],"gpt_icon":0},{"id":"2550652176","title":"Regenxbio Inc.盘中异动 下午盘股价大涨5.03%报9.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550652176","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550652176?lang=zh_cn&edition=full","pubTime":"2025-07-10 01:06","pubTimestamp":1752080808,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日01时06分，Regenxbio Inc.股票出现异动，股价快速上涨5.03%。截至发稿，该股报9.18美元/股，成交量20.8695万股，换手率0.41%，振幅5.78%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.95%。Regenxbio Inc.公司简介：Regenxbio Inc 是一家生物技术公司。Regenxbio 平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。消息层面，截至01时06分，《加皇资本市场维持Regenxbio买入评级，下调目标价至21美元》资讯为影响Regenxbio Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710010649979fe36e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710010649979fe36e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4505","RGNX","BK4139"],"gpt_icon":0},{"id":"2518618275","title":"Regenxbio Inc.盘中异动 大幅下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518618275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518618275?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:43","pubTimestamp":1741617829,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时43分，Regenxbio Inc.股票出现波动，股价快速跳水5.05%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3488.18%、763.71%、655.35%，振幅较大的相关个股有Scisparc Ltd.、Dogwood Therapeutics, Inc.、Biodexa Pharmaceuticals Plc，振幅分别为45.06%、41.36%、40.33%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022434998a2aef9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022434998a2aef9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGNX","BK4563","BK4505","BK4139"],"gpt_icon":0},{"id":"2517924359","title":"Regenxbio Inc.盘中异动 快速上涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517924359","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517924359?lang=zh_cn&edition=full","pubTime":"2025-03-06 04:54","pubTimestamp":1741208046,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时54分，Regenxbio Inc.股票出现波动，股价大幅拉升5.15%。截至发稿，该股报6.23美元/股，成交量59.3174万股，换手率1.20%，振幅6.25%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为1.91%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306045406a261314c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306045406a261314c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RGNX","BK4563","BK4505"],"gpt_icon":0},{"id":"2516670723","title":"Regenxbio Inc.盘中异动 早盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516670723","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516670723?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:52","pubTimestamp":1741099954,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时52分，Regenxbio Inc.股票出现波动，股价急速跳水5.06%。截至发稿，该股报5.62美元/股，成交量11.8075万股，换手率0.24%，振幅3.38%。Regenxbio Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Regenxbio Inc.公司简介：Regenxbio Inc是一家生物技术公司。Regenxbio平台针对的疾病是代谢性疾病、神经退行性疾病和视网膜疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422523496394b43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422523496394b43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","RGNX","BK4139","BK4563"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.regenxbio.com","stockEarnings":[{"period":"1week","weight":-0.0417},{"period":"1month","weight":0.0536},{"period":"3month","weight":0.3011},{"period":"6month","weight":0.5526},{"period":"1year","weight":0.7265},{"period":"ytd","weight":-0.0576}],"compareEarnings":[{"period":"1week","weight":-0.0103},{"period":"1month","weight":-0.0011},{"period":"3month","weight":0.0209},{"period":"6month","weight":0.0925},{"period":"1year","weight":0.1685},{"period":"ytd","weight":0.0018}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Regenxbio Inc.于2008年7月16日成立。该公司是一家领先的生物技术公司，专注于重组腺相关病毒基因疗法的发展，商业化和许可。在AAV基因治疗，病毒基因从所述AAV，一个小的非致病性感冒病毒除去，产生所谓的载体的生物递送载体。治疗性基因的序列然后被插入，形成重组载体。该公司专有的AAV基因交付平台包括专有权超过100新型AAV载体，包括AAV7，AAV8，AAV9和AAVrh10。公司的使命是将患者的生命从严重的疾病，患有显著未满足的医疗需求，通过开发和商业化直接给予体内基因治疗产品，或者体内，根据其资产净值技术平台上。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":-0.075852},{"month":2,"riseRate":0.3,"avgChangeRate":0.019547},{"month":3,"riseRate":0.6,"avgChangeRate":0.015225},{"month":4,"riseRate":0.6,"avgChangeRate":0.035795},{"month":5,"riseRate":0.3,"avgChangeRate":-0.022478},{"month":6,"riseRate":0.6,"avgChangeRate":0.047674},{"month":7,"riseRate":0.4,"avgChangeRate":-0.001741},{"month":8,"riseRate":0.4,"avgChangeRate":0.017624},{"month":9,"riseRate":0.6,"avgChangeRate":0.07131},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.060741},{"month":11,"riseRate":0.727273,"avgChangeRate":0.164969},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.05132}],"exchange":"NASDAQ","name":"Regenxbio Inc","nameEN":"Regenxbio"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Regenxbio Inc(RGNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Regenxbio Inc(RGNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Regenxbio Inc,RGNX,Regenxbio Inc股票,Regenxbio Inc股票老虎,Regenxbio Inc股票老虎国际,Regenxbio Inc行情,Regenxbio Inc股票行情,Regenxbio Inc股价,Regenxbio Inc股市,Regenxbio Inc股票价格,Regenxbio Inc股票交易,Regenxbio Inc股票购买,Regenxbio Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Regenxbio Inc(RGNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Regenxbio Inc(RGNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}